European NGOs back Indian generic drugs

Image
Press Trust of India London
Last Updated : Jan 21 2013 | 12:29 AM IST

Renowned European NGOs, including Oxfam and Medecins Sans Frontieres, have thrown their weight behind the Indian generic drug industry, whose products have been seized by authorities in Europe alleging violation of patents.

"If the current EU trade policy remains, it will have a disastrous impact on the lives of millions... The Indian generic medicines industry, which exports two-thirds of its production to developing countries, could face restrictions," a joint declaration by Oxfam, Health Action International and Medicins Sans Frontieres said here.

The generic drugs are those on which the patents have lapsed and can be manufactured by anyone.

In his recent visit to New Delhi, Director General of Geneva-based World Intellectual Property Francis Gurry corroborated the point that generic drugs do not violate any patents.

Over the last one year, European authorities have seized over 18 generic consignments of Indian companies en route Latin America and Africa, alleging violation of patents.

The issue has repeatedly been taken up by the Commerce Ministry with the European authorities.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 19 2009 | 6:43 PM IST

Next Story